Olympus Medical Systems

Name

Olympus Medical Systems

Legal name

Olympus Corporation of the Americas

Website

https://medical.olympusamerica.com

Company type

Public

Founded year

1919

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Medical Endoscopy Systems

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industry

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

• Medical endoscopy systems
• Surgical imaging platforms
• Minimally invasive treatment
• Endoscopic ultrasound
• Respiratory bronchoscopy

Headquarters

HQ city

Center Valley

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Capital Equipment Sales: Olympus generates revenue from sale of capital medical equipment including endoscopy systems, surgical imaging platforms, ultrasound processors, and reusable surgical devices to hospitals and healthcare systems.
2. Single-Use Medical Devices: Recurring revenue from single-use devices including bronchoscopes, rhinolaryngoscopes, biopsy needles, surgical sealers, and accessories used in procedures.
3. Service and Repair: Olympus provides service and repair capabilities through MyOlympus Service portal, service agreements, and certified pre-owned equipment programs.
4. Financing and Leasing Programs: Olympus offers leasing and financing programs for healthcare facilities to acquire capital equipment, providing flexible payment options.

Pricing tiers

Go-to-market motion3 records

Distribution channels7 records

Marketing channels7 records

Core offering

Olympus Medical Systems develops, manufactures, and distributes endoscopy systems, surgical imaging platforms, and minimally invasive therapeutic devices for the early detection, diagnosis, and treatment of gastrointestinal, urological, respiratory, and surgical conditions in healthcare facilities. Its portfolio spans capital equipment, single-use devices, and AI-enabled software platforms serving hospitals, ambulatory surgical centers, and federal healthcare facilities.

Product overview

Olympus Medical Systems offers a comprehensive portfolio of medical devices and platforms for endoscopy-enabled care across gastroenterology, urology, respiratory/pulmonology, and surgical specialties. The portfolio includes core endoscopy systems (EVIS X1), surgical imaging platforms (VISERA ELITE III developed with Sony), ultrasound systems (Aplio i800 EUS via Canon partnership, EU-ME3), AI-enabled detection solutions (OLYSENSE platform with CADDIE), single-use scopes (H-SteriScope bronchoscopes, E-SteriScope rhinolaryngoscopes), surgical energy devices (POWERSEAL, Thunderbeat), advanced visualization scopes (ENDOEYE 3D, ENDOCUFF VISION), tissue management tools (DIEGO ELITE, Celeris), ERCP devices (TJF-Q190V duodenoscope, VisiGlide, CleverCut3V), and workflow management platforms (Knowledge Exchange System, EBUS Solution, Systems Integration). The company also distributes third-party products (GORE VIABIL stents) and is expanding through acquisitions (BioProtect Balloon Spacer) and partnerships (EndoRobotics robotics).

Differentiator

Problem solved

Functional benefit

Brands

• EVIS X1: Advanced endoscopy system featuring Extended Depth of Field (EDOF) technology for precise observation through continuous broad focus and seamless magnification.
• VISERA ELITE III
• POWERSEAL
• H-SteriScope
• OLYSENSE
• ENDOEYE FLEX 3D
• Thunderbeat
• Spiration Valve System
• SecureFlex FNB
• E-SteriScope
• Olympus Innovation Ventures (OIV)

Products and services

• EVIS X1 Endoscopy System
• VISERA ELITE III Surgical Imaging Platform
• OLYSENSE Platform
• Aplio i800 EUS Ultrasound System
• EU-ME3 Ultrasound Processor
• H-SteriScope Single-Use Bronchoscopes
• E-SteriScope Single-Use Rhinolaryngoscope
• Thunderbeat Tissue Management
• POWERSEAL Sealer/Divider
• ENDOEYE FLEX 3D
• DIEGO ELITE Multidebrider
• Celeris Single-Use Microdebrider
• TJF-Q190V Duodenoscope
• SecureFlex FNB Needle
• CleverCut3V Sphincterotomes
• VisiGlide Guidewires
• HD Flexible Cystoscope
• Plasma-OvalButton
• Olympus EBUS Solution
• Olympus Knowledge Exchange System
• Olympus Systems Integration
• BioProtect Balloon Spacer
• EndoRobotics Robot-Assisted Technologies

Quantifiable outcome

• 7.3% absolute increase in adenoma detection rate (ADR) with CADDIE AI-assisted colonoscopy vs standard colonoscopy
• +5 more outcomes

Named customers8 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature12 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• BioProtect Ltd.coreStrategic or Co-development Partner · 26 May 2026Olympus announced definitive agreement to acquire BioProtect Ltd. for $270 million to expand portfolio of urological technologies and address prostate cancer. BioProtect develops the Balloon Spacer system for rectal spacing during prostate cancer radiation therapy, which has been used in 11,000+ procedures worldwide. Acquisition aligns with Olympus' strategic pillar of Innovation-driven Growth.
• Hunan Vathin Medical Instrument Co., Ltd.coreOEM/ Whitelabel/ Licensing Partner · 14 May 2026Vathin E-SteriScope single-use rhinolaryngoscopes and H-SteriScope single-use bronchoscopes manufactured by Vathin Medical are distributed exclusively by Olympus. The products complement Olympus' reusable scope portfolio with single-use options for enhanced patient safety and procedural flexibility.
• EndoRobotics Co., Ltd.coreTechnology or Integration · 4 May 2026Exclusive global distribution agreement for robot-assisted technologies manufactured by EndoRobotics as part of Olympus' EndoTherapy portfolio. Partnership aims to drive broader adoption of advanced endoscopic procedures such as endoscopic submucosal dissection (ESD) and help clinicians deliver organ-sparing, minimally invasive care with precision and confidence.
• Canon Inc./Canon Medical Systems USAcoreTechnology or Integration · 1 May 2026Strategic partnership for exclusive distribution of Canon-manufactured Aplio i800 EUS premium ultrasound system in the U.S., its territories, Puerto Rico, and Bermuda. The system offers advanced EUS imaging with Shear Wave Elastography, Attenuation Imaging, Superb Micro-vascular Imaging, and Smart 3D capabilities for GI and pulmonary applications.
• First Nation GroupcoreChannel Partner/ Reseller/ Distributor · 1 May 2026Authorized SDVOSB reseller agreement for federal healthcare facilities. First Nation Group, a Service-Disabled Veteran-Owned Small Business, provides federal customers including VA, DoD, IHS, and NIH with access to Olympus capital equipment and single-use devices. The 3-year agreement supports government agencies in achieving SDVOSB procurement objectives.
• DSS Imagetech / MBF BioscienceminorStrategic or Co-development Partner · 24 April 2026Expert-led webinar series celebrating 'Microscopy Month' and World Microscopy Day featuring sessions on advanced imaging technologies including SLICE light sheet imaging, Abberior Super Resolution Nanoscopy, and Evident Microscopy solutions. Olympus Medical Systems India participates as expert panel member.
• Campanha Marco Azul (SOBED, SBCP, FBG)minorStrategic or Co-development Partner · 25 March 2026Olympus Grants Committee approved short-term product loan supporting Brazil's Campanha Marco Azul colorectal cancer awareness initiative. Loan enabled 624 no-cost colonoscopies, removal of 300+ polyps, and diagnosis of 8 advanced cancers in underserved population.
• American Society of Gastrointestinal Endoscopy (ASGE)coreStrategic or Co-development Partner · 18 March 2026ASGE, a nonprofit medical society with more than 17,000 members worldwide, received a $1 million+ permanent product award from Olympus including six EVIS X1 endoscopy systems. Equipment supports hands-on training at ASGE's Institute of Training and Technology serving approximately 1,200 learners annually including nearly 500 first-year fellows.
• W. L. Gore & AssociatescoreOEM/ Whitelabel/ Licensing Partner · 5 December 2025Exclusive global distribution rights for GORE VIABIL Biliary Endoprosthesis transferred from Gore to Olympus. The fully covered self-expanding metal stent provides differentiated alternative for palliation of malignant biliary strictures. Commercial support transitioned to Olympus January 1, 2026.
• ConMed CorporationminorChannel Partner/ Reseller/ Distributor · 5 December 2025ConMed previously supported GORE VIABIL Biliary Endoprosthesis distribution in the U.S. until December 31, 2025. The transition ensures continuity of service and access for healthcare providers and patients during the commercial change to Olympus distribution.
• Swan EndoSurgicalminorStrategic or Co-development Partner · 2 December 2025Swan EndoSurgical is an emerging leader in flexible endoluminal surgical robotics, co-founded by Revival Healthcare Capital and Olympus. Company is focused on delivering a fully integrated flexible endoluminal robotic platform for complex gastrointestinal interventions.

Scale indicators8 records

Recent moves8 records

Expansion highlights7 records

Broad incumbents

• Stryker: Diversified MedTech incumbent with a large surgical and endoscopy portfolio (1588/1688 AIM camera platforms, surgical visualization, PowerSeal-style energy devices) and a Robotics & Enabling Technologies division. Overlaps with Olympus in surgical imaging, energy, and increasingly single-use scopes.
• Medtronic: Broad incumbent in GI (GI Genius AI polyp detection), surgical stapling, energy, and advanced ablation. Specifically competes with Olympus in GI AI detection, colorectal surgery, and ENT/pulmonary platforms; named alongside Olympus as a key player in the lung cancer surgery market.
• Ethicon (Johnson & Johnson MedTech): Broad incumbent in advanced and laparoscopic surgical energy (ENSEAL, HARMONIC), stapling, and biosurgery. Competes directly with Olympus POWERSEAL and THUNDERBEAT in the same multi-specialty minimally invasive surgery capital sales cycles.

Emerging players

• Intuitive Surgical: Adjacent competitor in minimally invasive surgery via the da Vinci robotic platform and emerging Ion robotic bronchoscopy for lung biopsy. Represents the primary long-term competitive risk to Olympus' surgical imaging and lung cancer franchises as robotic surgery expands.
• Teleflex: Emerging competitor in interventional pulmonology and urology with single-use bronchoscopes (Muffin, TotalDrive) and urological devices. Listed alongside Olympus as a key player in the lung cancer surgery market with a meaningful but more focused portfolio overlap.

Direct peers

• Boston Scientific: Direct peer in GI endoscopy (SpyGlass DS cholangioscopy, hemostasis clips, resection devices), urology (LithoVue ureteroscopy, Rezum BPH), and pulmonary (single-use bronchoscopy via the acquisition of Apollo Endosurgery and other assets). Heavily overlaps Olympus' therapeutic endotherapy and single-use franchises.
• Pentax Medical (HOYA): Direct peer in flexible endoscopy systems (i20, OPTIVISTA) with strong i-scan imaging and growing single-use bronchoscope offerings. Competes against EVIS X1 in GI and increasingly in therapeutic pulmonology and ENT.
• Karl Storz: German privately-held endoscopy systems and instruments manufacturer that competes head-to-head with Olympus across rigid and flexible endoscopy, laparoscopy, and urology visualization. Most direct peer in core endoscopy towers (rigid/flexible scopes, cameras, light sources) and a frequent co-bidder in hospital capital tenders.
• Fujifilm Healthcare: Direct peer in endoscopy towers (ELUXEO, BL-7000 series), EUS, and AI-assisted colonoscopy via its REiLI platform. Third-party AI vendors (L Pixel) explicitly build compatibility for both Olympus and Fujifilm systems, underscoring their head-to-head positioning.

Regional players

• ConMed: Surgical and gastrointestinal competitor in insufflation, electrosurgery, and endomechanical devices. Previously distributed GORE VIABIL biliary stents in the U.S. through end of 2025, then transitioned commercial support to Olympus—illustrating direct overlap in the Olympus EndoTherapy customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/OlympusMedUS
• YouTubeyoutube.com/c/OlympusMedicalAmerica
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/showcase/olympus-medical-americas
• Instagraminstagram.com/olympusamericas

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olympus Medical Systems